Total Payments
$3,048
2024 Payments
$779.91
Companies
18
Transactions
225
Medicare Patients
958
Medicare Billing
$53,523
Payment Breakdown by Category
Food & Beverage$2,865 (94.0%)
Education$182.55 (6.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,865 | 222 | 94.0% |
| Education | $182.55 | 3 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $784.51 | 92 | $0 (2024) |
| ABBVIE INC. | $515.03 | 40 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $348.55 | 26 | $0 (2024) |
| GENZYME CORPORATION | $198.04 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $185.43 | 8 | $0 (2024) |
| Incyte Corporation | $168.14 | 8 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $166.66 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $132.33 | 5 | $0 (2024) |
| Lilly USA, LLC | $109.10 | 6 | $0 (2024) |
| UCB, Inc. | $91.46 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $779.91 | 47 | E.R. Squibb & Sons, L.L.C. ($165.38) |
| 2023 | $1,029 | 67 | Janssen Biotech, Inc. ($231.62) |
| 2022 | $797.35 | 69 | Janssen Biotech, Inc. ($225.41) |
| 2021 | $441.89 | 42 | Janssen Biotech, Inc. ($191.25) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.03 | General |
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.23 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: Immunology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.62 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: Immunology | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: Immunology | ||||||
| 11/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Immunology | ||||||
| 07/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.92 | General |
| Category: Immunology | ||||||
| 07/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.04 | General |
| Category: Immunology | ||||||
| 07/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| Category: Dermatology | ||||||
| 07/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.16 | General |
| Category: Immunology | ||||||
| 07/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Immunology | ||||||
| 07/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: Immunology | ||||||
| 06/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.99 | General |
| Category: Immunology | ||||||
| 06/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: IMMUNOLOGY | ||||||
| 05/28/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.75 | General |
| 05/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $35.65 | General |
| Category: Immunology | ||||||
| 05/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Immunology | ||||||
| 05/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.39 | General |
| Category: Immunology | ||||||
| 04/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.37 | General |
| Category: Immunology | ||||||
| 04/24/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 13 | 574 | 885 | $137,783 | $30,323 |
| 2020 | 9 | 384 | 646 | $96,159 | $23,199 |
Total Patients
958
Total Services
1,531
Medicare Billing
$53,523
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 183 | 191 | $33,813 | $8,157 | 24.1% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 27 | 31 | $22,661 | $6,214 | 27.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 101 | 106 | $16,867 | $2,901 | 17.2% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 18 | 23 | $9,729 | $1,960 | 20.1% |
| 11301 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs | Office | 2021 | 25 | 30 | $8,640 | $1,636 | 18.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 24 | 24 | $6,360 | $1,583 | 24.9% |
| 11300 | Shaving of 0.5 centimeters or less skin growth of the trunk, arms, or legs | Office | 2021 | 29 | 36 | $8,388 | $1,489 | 17.7% |
| 11602 | Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Office | 2021 | 16 | 16 | $9,584 | $1,427 | 14.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 80 | 354 | $4,945 | $1,307 | 26.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 24 | 25 | $5,980 | $1,296 | 21.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 22 | $5,786 | $1,218 | 21.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $3,652 | $755.48 | 20.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 13 | $1,378 | $379.30 | 27.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 105 | 108 | $28,404 | $6,993 | 24.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 66 | 73 | $12,921 | $3,420 | 26.5% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2020 | 11 | 13 | $9,503 | $2,649 | 27.9% |
| 17000 | Destruction of skin growth | Office | 2020 | 69 | 82 | $13,120 | $2,616 | 19.9% |
| 11301 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs | Office | 2020 | 29 | 36 | $10,368 | $2,382 | 23.0% |
| 11300 | Shaving of 0.5 centimeters or less skin growth of the trunk, arms, or legs | Office | 2020 | 30 | 35 | $8,155 | $1,718 | 21.1% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2020 | 12 | 15 | $6,345 | $1,617 | 25.5% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 49 | 271 | $3,794 | $1,061 | 28.0% |
| 11310 | Shaving of 0.5 centimeters or less skin growth of face, ears, eyelids, nose, lips, or mouth | Office | 2020 | 13 | 13 | $3,549 | $743.22 | 20.9% |
About Molly Mcintyre, PA-C
Molly Mcintyre, PA-C is a Medical healthcare provider based in Coraopolis, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2011. The National Provider Identifier (NPI) number assigned to this provider is 1942596457.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Molly Mcintyre, PA-C has received a total of $3,048 in payments from pharmaceutical and medical device companies, with $779.91 received in 2024. These payments were reported across 225 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,865).
As a Medicare-enrolled provider, Mcintyre has provided services to 958 Medicare beneficiaries, totaling 1,531 services with total Medicare billing of $53,523. Data is available for 2 years (2020–2021), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Coraopolis, PA
- Active Since 06/22/2011
- Last Updated 10/03/2012
- Taxonomy Code 363AM0700X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942596457
Products in Payments
- TREMFYA (Drug) $508.83
- Sotyktu (Drug) $338.12
- SKYRIZI (Biological) $308.68
- DUPIXENT (Biological) $287.02
- REMICADE (Biological) $275.68
- OPZELURA (Drug) $168.14
- RINVOQ (Biological) $153.74
- TALTZ (Drug) $109.10
- COSENTYX (Drug) $94.82
- ILUMYA (Biological) $88.56
- Winlevi (Drug) $78.10
- Bimzelx (Biological) $77.53
- VTAMA (Drug) $76.01
- EUCRISA (Drug) $66.66
- Otezla (Drug) $51.93
- ADBRY (Biological) $48.92
- COSENTYX (Biological) $35.83
- AKLIEF (Drug) $31.37
- HUMIRA (Biological) $27.81
- Seysara (Drug) $24.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.